Initial microbial spectrum in severe secondary peritonitis and relevance for treatment

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 31, Issue 5, 2012, Pages 671-682

  Van Ruler, O ^a   Kiewiet, J J S ^a   Van Ketel, R J ^a   Boermeester, M A ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; GENTAMICIN; METRONIDAZOLE;

ABDOMINAL INFECTION; ADULT; AGED; ANAEROBIC BACTERIUM; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM CULTURE; COLIFORM BACTERIUM; CONTROLLED STUDY; DEATH; DISEASE SEVERITY; EMERGENCY SURGERY; ENTEROCOCCUS; FEMALE; FUNGUS CULTURE; GRAM POSITIVE COCCI; HOSPITAL PATIENT; HUMAN; INFECTION RISK; LAPAROTOMY; MAJOR CLINICAL STUDY; MALE; MICROBIOLOGICAL EXAMINATION; MULTIDRUG RESISTANCE; NONHUMAN; PERITONITIS; PREDICTION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RANDOMIZED CONTROLLED TRIAL; REOPERATION; YEAST;

EID: 84859912949     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-011-1357-0     Document Type: Article

References (33)

1. Lamme B, Mahler CW, van Till JW, van Ruler O, Gouma DJ, Boermeester MA (2005) Relaparotomy in secondary peritonitis. Planned relaparotomy or relaparotomy on demand? Chirurg 76: 856-867
2. Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, Gea-Banacloche J, Keh D, Marshall JC, Parker MM, Ramsay G, Zimmerman JL, Vincent JL, Levy MM (2004) Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 32: 858-873
3. Ibrahim EH, Sherman G, Ward S, Fraser VJ, Kollef MH (2000) The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 118: 146-155
4. Kollef MH, Sherman G, Ward S, Fraser VJ (1999) Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest 115: 462-474
5. Anaya DA, Nathens AB (2003) Risk factors for severe sepsis in secondary peritonitis. Surg Infect (Larchmt) 4: 355-362
6. Bohnen J, Boulanger M, Meakins JL, McLean AP (1983) Prognosis in generalized peritonitis. Relation to cause and risk factors. Arch Surg 118: 285-290
7. Fry DE, Garrison RN, Heitsch RC, Calhoun K, Polk HC Jr (1980) Determinants of death in patients with intraabdominal abscess. Surgery 88: 517-523
8. Grunau G, Heemken R, Hau T (1996) Predictors of outcome in patients with postoperative intra-abdominal infection. Eur J Surg 162: 619-625
9. Holzheimer RG, Gathof B (2003) Re-operation for complicated secondary peritonitis-how to identify patients at risk for persistent sepsis. Eur J Med Res 8: 125-134
10. Lamme B, Mahler CW, van Ruler O, Gouma DJ, Reitsma JB, Boermeester MA (2006) Clinical predictors of ongoing infection in secondary peritonitis: systematic review. World J Surg 30: 2170-2181
11. Pusajo JF, Bumaschny E, Doglio GR, Cherjovsky MR, Lipinszki AI, Hernandez MS, Egurrola MA (1993) Postoperative intraabdominal sepsis requiring reoperation. Value of a predictive index. Arch Surg 128: 218-222
12. van Ruler O, Mahler CW, Boer KR, Reuland EA, Gooszen HG, Opmeer BC, de Graaf PW, Lamme B, Gerhards MF, Steller EP, van Till JW, de Borgie CJ, Gouma DJ, Reitsma JB, Boermeester MA, Dutch Peritonitis Study Group (2007) Comparison of ondemand versus planned relaparotomy strategy in patients with severe peritonitis. A randomized trial. JAMA 298 (8): 865-872
13. van Goor H (2002) Interventional management of abdominal sepsis: when and how. Langenbecks Arch Surg 387: 191-200
14. van Ruler O, Lamme B, Gouma DJ, Reitsma JB, Boermeester MA (2007) Variables associated with positive findings at relaparotomy in patients with secondary peritonitis. Crit Care Med 35: 468-476
15. Wacha H, Hau T, Dittmer R, Ohmann C (1999) Risk factors associated with intraabdominal infections: a prospective multicen-ter study. Peritonitis Study Group. Langenbecks Arch Surg 384: 24-32
16. Wacha H, Linder MM, Feldmann U, Wesch G, Gundlach E, Steifensand RA (1987) Mannheim Peritonitis Index-prediction of risk of death from peritonitis: construction of a statistical and validation of an emperically based index. Theor Surg 169-177
17. Wittmann DH, Muller M (1987) Patient stratification in intraabdominal infection. Chemioterapia 6: 460-462
18. Solomkin JS, Mazuski JE, Baron EJ, SawyerRG, NathensAB, DiPiro JT, Buchman T, Dellinger EP, Jernigan J, Gorbach S, Chow AW, Bartlett J (2003) Guidelines for the selection of anti-infective agents for complicated intra-abdominal infections. Clin Infect Dis 37: 997-1005
19. Wong PF, Gilliam AD, Kumar S, Shenfine J, O'Dair GN, Leaper DJ (2005) Antibiotic regimens for secondary peritonitis of gastrointestinal origin in adults. Cochrane Database Syst Rev CD004539
20. Barie PS, Hydo LJ, Shou J, Larone DH, Eachempati SR (2005) Influence of antibiotic therapy on mortality of critical surgical illness caused or complicated by infection. Surg Infect (Larchmt) 6: 41-54
21. Barie PS, Christou NV, Dellinger EP, Rout WR, Stone HH, Waymack JP (1990) Pathogenicity of the enterococcus in surgical infections. Ann Surg 212: 155-159
22. Chatterjee I, Iredell JR, Woods M, Lipman J (2007) The implications of enterococci for the intensive care unit. Crit Care Resusc 9: 69-75
23. Christou NV, Turgeon P, Wassef R, Rotstein O, Bohnen J, Potvin M (1996) Management of intra-abdominal infections. The case for intraoperative cultures and comprehensive broad-spectrum antibiotic coverage. The Canadian Intra-abdominal Infection Study Group. Arch Surg 131: 1193-1201
24. Garbino J, Villiger P, Caviezel A, Matulionyte R, Uckay I, Morel P, Lew D (2007) A randomized prospective study of cefepime plus metronidazole with imipenem-cilastatin in the treatment of intraabdominal infections. Infection 35: 161-166
25. Harbarth S, Uckay I (2004) Are there patients with peritonitis who require empiric therapy for enterococcus? Eur J Clin Microbiol Infect Dis 23: 73-77
26. Krobot K, Yin D, Zhang Q, Sen S, Altendorf-Hofmann A, Scheele J, Sendt W (2004) Effect of inappropriate initial empiric antibiotic therapy on outcome of patients with community-acquired intraabdominal infections requiring surgery. Eur J Clin Microbiol Infect Dis 23 (9): 682-687
27. Solomkin JS, Wilson SE, Christou NV, Rotstein OD, Dellinger EP, Bennion RS, Pak R, Tack K (2001) Results of a clinical trial of clinafloxacin versus imipenem/cilastatin for intraabdominal infections. Ann Surg 233: 79-87
28. Top J, Willems R, Blok H, de Regt M, Jalink K, Troelstra A, Goorhuis B, Bonten M (2007) Ecological replacement of Enterococcus faecalis by multiresistant clonal complex 17 Enterococcus faecium. Clin Microbiol Infect 13: 316-319
29. Wacha H, Warren B, Bassaris H, Nikolaidis P (2006) Comparison of sequential intravenous/oral ciprofloxacin plus metronidazole with intravenous ceftriaxone plus metronidazole for treatment of complicated intra-abdominal infections Surg. Infect (Larchmt) 7: 341-354
30. Nethmap (2009) Consumption of antimicrobial agents and antimicrobial resistance among medically important bacteria in the Netherlands. Available at www.swab.nl. Accessed 05 January2011
31. van Till JWO, van Ruler O, Lamme B, Weber RJP, Reitsma JB, Boermeester MA (2007) Single-drug therapy or selective decontamination of the digestive tract as antifungal prophylaxis in critically ill patients: a systematic review. Crit Care 11
32. Driscoll JA, Brody SL, Kollef MH (2007) The epidemiology, pathogenesis and treatment of Pseudomonas aeruginosa infections. Drugs 67: 351-368
33. Herold CJ, Sailer JG (2004) Community-acquired and nosocomial pneumonia. Eur Radiol 14 (Suppl 3): E2-E20